InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by WHITNELL JEFFREY A, Director. Officer active across 1 company, notably Elite Pharmaceuticals INC. Cumulatively, 4 disclosures have been recorded. Activity tracked since 30 June 2021. The latest transaction was filed on 22 November 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations
Jeffrey A. Whitnell is a Director at ELITE PHARMACEUTICALS INC /NV/. In this role, he contributes to the governance of the company and strategic decision-making. Jeffrey brings expertise in the pharmaceutical sector, which is essential for guiding product development and regulatory compliance initiatives. His commitment to innovation and quality is crucial for the long-term success of the company.